首页> 外文OA文献 >Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study

【2h】

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study

机译：胰高血糖素肽-1受体激动剂植物苷的疗效和安全性加入胰岛素治疗中的1型糖尿病患者的胰岛素治疗 - 一种用于随机，双盲，安慰剂对照研究的方案：Lira-1研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
T. F. Dejgaard; F. K. Knop; L. Tarnow; C. S. Frandsen; T. S. Hansen; T. Almdal; J. J. Holst; S. Madsbad; H. U. Andersen;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study [J] . Christian Seerup Frandsen, Filip Krag Knop, Henrik Ullits Andersen, BMJ Open . 2015,第4期

机译：胰高血糖素样肽-1受体激动剂利拉鲁肽在胰岛素治疗中添加的胰岛素治疗对管理不善的1型糖尿病患者的疗效和安全性-一项随机，双盲，安慰剂对照研究的方案：Lira-1研究
2. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study [J] . Kumarathurai Preman, Anholm Christian, Fabricius-Bjerre Andreas, Journal of hypertension . 2017,第5期

机译：胰高血糖素样肽-1受体激动剂Ziraglutide对2型糖尿病患者24-H动态血压的影响：随机，双盲，安慰剂控制，交叉研究
3. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study [J] . Preman Kumarathurai, Christian Anholm, Olav W. Nielsen, Cardiovascular Diabetology . 2016,第1期

机译：胰高血糖素样肽1受体激动剂利拉鲁肽对冠心病和2型糖尿病患者的收缩功能的影响：一项随机双盲安慰剂对照交叉研究
4. A randomized, open-label, intervention study to evaluate the effect of diet composition on weight gain in obese, type 2 diabetes patients receiving intensive insulin therapy. [D] . Villareal, Roland. 2008

机译：一项随机，开放标签，干预性研究，以评估饮食结构对接受强化胰岛素治疗的肥胖2型糖尿病患者体重增加的影响。
5. Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised double-blind placebo-controlled study: The Lira-1 study [O] . Thomas Fremming Dejgaard, Filip Krag Knop, Lise Tarnow, 2015

机译：胰高血糖素样肽-1受体激动剂利拉鲁肽在胰岛素治疗中添加的胰岛素治疗对管理不善的1型糖尿病患者的疗效和安全性-一项随机双盲安慰剂对照研究的方案：Lira-1研究
6. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study [O] . 2016

机译：胰高血糖素样肽1受体激动剂利拉鲁肽对冠心病和2型糖尿病患者收缩功能的影响：一项随机双盲安慰剂对照交叉研究

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study

著录项

相似文献

相关主题

期刊订阅